
Laneige

Eye Masks
Some ingredients carry a low-risk flag. Read the formulation context before deciding.
32 of 32 ingredients rated
MamaSkin rates the recorded formula for Laneige Bouncy & Firm Eye Brightening Sleeping Mask with Peony + Collagen Complex as Low risk (79/100). Review the ingredient context and any manual-review explanation before deciding.
Manual review 2026-07-13: The recorded formula was manually reviewed. This formula contains Dipotassium Glycyrrhizate, classified as low risk under MamaSkin's pregnancy-screening policy. This is a cautious classification, not a known pregnancy contraindication; see the highlighted ingredient entry for its rationale and sources.
32 of 32 ingredient entries on this page have a recorded score, evidence summary and source text. That describes documentation coverage, not proof that the finished formula has been clinically tested during pregnancy.
How we assess productsThe recorded formula, with evidence behind each rating. Unmatched ingredients are marked Not assessed in grey.
A purified glycyrrhizic-acid salt used as a soothing and skin-conditioning ingredient. Cosmetic safety reviewers concluded that dipotassium glycyrrhizate is safe in current cosmetic use and noted poor dermal absorption. MamaSkin nevertheless applies a cautious low-risk classification for consistency with the existing licorice family because high oral glycyrrhizin exposure has pregnancy-related concerns; this is not a topical contraindication.
Sources: CIR: Safety Assessment of Glycyrrhizic Acid and Derivatives https://cir-reports.cir-safety.org/view-attachment/?id=49a63435-8e74-ec11-8943-0022482f06a6
Glycerin is a widely used humectant that supports hydration and the skin barrier, with a long safety record and no known pregnancy or breastfeeding concerns in topical cosmetic use.
Sources: CIR; EU/UK Cosmetics Regulation
A high-molecular-weight polymer used to thicken and stabilise cosmetics. CIR included Sodium Acrylates Crosspolymer-2 in the acrylates-copolymer safe-as-used conclusion when formulated to be non-irritating. This conclusion concerns the finished polymer with appropriate residual-monomer controls, not free acrylate monomers; no pregnancy-specific topical concern was identified.
Sources: CIR: Amended Safety Assessment of Acrylates Copolymers as Used in Cosmetics https://www.cir-safety.org/sites/default/files/Acrylates%20Copolymers_0.pdf
Solvent and humectant commonly used in leave-on products. Not associated with pregnancy-specific concerns at cosmetic exposure levels.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
Niacinamide (vitamin B3) is widely used for barrier support and tone/texture benefits, and is generally considered safe in pregnancy and breastfeeding when used topically at cosmetic concentrations.
Sources: CIR; EU/UK Cosmetics Regulation
1,2-Hexanediol is commonly used as a solvent and preservative booster; topical exposure is low and it has no known pregnancy or breastfeeding concerns at cosmetic concentrations, though very sensitive skin may occasionally react.
Sources: CIR; EU/UK Cosmetics Regulation
Panthenol (pro-vitamin B5) is used for soothing and barrier support and is generally well tolerated, with no known pregnancy or breastfeeding concerns in topical cosmetic use.
Sources: CIR; EU/UK Cosmetics Regulation
A small glycerin polymer used as a humectant and conditioning ingredient. Cosmetic safety reviewers assessed polyglycerin-3 with diglycerin and related polyglycerins and concluded that they are safe in current practices of use and concentration. No pregnancy-specific concern was identified for normal topical use.
Sources: CIR: Safety Assessment of Diglycerin and Polyglycerins as Used in Cosmetics https://www.cir-safety.org/panelbook/safety-assessment-diglycerin-and-polyglycerin-3-6-and-10-used-cosmetics
A high-molecular-weight moisturising and texture polymer. Cosmetic safety reviewers concluded that glyceryl polymethacrylate is safe in current cosmetic practices. Dermal absorption of the intact polymer is expected to be limited, and residual monomers should be controlled.
Sources: CIR: Final safety assessment of Glyceryl Polymethacrylate, June 2022; December 2025 Quick Reference Table https://cir-safety.org/sites/default/files/QRT-Update-Dec2025.pdf
Methylxanthine used in cosmetics (e.g., de-puffing/firming and antioxidant support). No pregnancy-specific contraindications are identified for topical cosmetic use.
Sources: CIR (Methylxanthines); PubMed (NLM)
A lysate produced from Lactobacillus fermentation and used for skin conditioning. Cosmetic safety reviewers concluded that Lactobacillus ferment lysate is safe in current practices of use and concentration.
Sources: CIR: Lactobacillus Ferment Lysate final safety assessment, September 2025; December 2025 Quick Reference Table https://cir-safety.org/sites/default/files/QRT-Update-Dec2025.pdf
Polymer thickener and stabiliser used in creams and sunscreens. Low systemic exposure expected.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
Solvent and humectant used to improve texture and ingredient solubility. Low systemic exposure expected from topical cosmetic use.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
Natural polysaccharide thickener used for stability and texture. Not associated with pregnancy-specific concerns.
Sources: European cosmetics regulatory framework
Preservative booster and skin-conditioning agent. Considered safe for cosmetic use with low systemic exposure when used as intended.
Sources: Scientific Committee on Consumer Safety (EU); Cosmetic Ingredient Review (US)
Skin-conditioning ingredient commonly used in leave-on skincare. Reviewed cosmetic safety sources support normal topical use, with no pregnancy- or breastfeeding-specific topical signal identified in the material reviewed.
Sources: CIR: Safety Assessment of Adenosine Ingredients as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory
A simple inorganic salt used to adjust viscosity, ionic strength, pH or formula stability. At normal cosmetic concentrations, no pregnancy-specific concern was identified from topical exposure. Concentrated raw material may irritate skin or eyes, so this assessment applies to a compliant finished cosmetic rather than occupational handling.
Sources: European Commission CosIng ingredient inventory; ECHA substance information for sodium chloride and marine salts, magnesium nitrate and sodium metaphosphate; CIR assessments of related magnesium and phosphate salts.
Humectant and preservative booster used to support product stability. Low systemic exposure expected from topical cosmetic use.
Sources: Scientific Committee on Consumer Safety (EU); Cosmetic Ingredient Review (US)
An amino acid or amino-acid mixture used for hydration and conditioning. No pregnancy-specific hazard was identified for normal topical exposure.
Sources: European Commission CosIng; peer-reviewed biochemical and cosmetic literature.
Protein-derived skin- and hair-conditioning ingredient used to support feel and hydration at the surface. Reviewed cosmetic ingredient references do not identify a pregnancy- or breastfeeding-specific concern for normal topical use.
Sources: CIR cosmetic ingredient safety references for protein hydrolysates; EU CosIng / cosmetics regulatory inventory
Starch-derived polysaccharide used as a binder, film former and texture support ingredient. Reviewed cosmetic ingredient references do not identify a pregnancy- or breastfeeding-specific concern for normal topical use.
Sources: CIR cosmetic ingredient safety references for polysaccharides/starch-derived ingredients; EU CosIng / cosmetics regulatory inventory
A fruit, seed or food-plant extract used for skin conditioning and antioxidant support. No pregnancy-specific signal was identified for the low topical exposure expected from a finished cosmetic. Direct pregnancy studies are generally unavailable, and botanical allergy remains possible.
Sources: European Commission CosIng ingredient inventory; CIR botanical safety framework and relevant fruit-derived ingredient assessments; peer-reviewed cosmetic and phytochemical literature for the named plants.
Sodium hyaluronate (hyaluronic acid salt) is used for hydration and cushioning, with very low systemic absorption from topical use and no known pregnancy or breastfeeding concerns at cosmetic concentrations.
Sources: CIR; EU/UK Cosmetics Regulation
A vitamin B ingredient or derivative used for skin or hair conditioning. These vitamins are normal nutrients and no pregnancy-specific concern was identified for the small topical exposure expected from a finished cosmetic. This assessment does not replace guidance about oral supplements or therapeutic doses.
Sources: NIH Office of Dietary Supplements vitamin fact sheets https://ods.od.nih.gov/factsheets/list-all/; CIR: Panthenol, Pantothenic Acid and Derivatives safety assessment https://www.cir-safety.org/supplementaldoc/safety-assessment-panthenol-pantothenic-acid-and-derivatives-used-cosmetics-1
A botanical extract, juice or water used primarily for skin conditioning, moisturising, soothing or antioxidant support. Direct pregnancy studies of the named cosmetic material were not identified. No reproductive or developmental hazard was identified for normal topical exposure to a compliant finished cosmetic; oral herbal or medicinal use is outside this classification.
Sources: European Commission CosIng ingredient inventory; Cosmetic Ingredient Review botanical safety-assessment framework and relevant plant-family assessments. No ingredient-specific human pregnancy study of normal topical cosmetic use was identified.
Vitamin E antioxidant used to protect oils and support the skin barrier. Not associated with pregnancy-specific concerns at cosmetic exposure.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
Humectant and skin-conditioning ingredient in the hyaluronate family. Reviewed cosmetic safety sources support current cosmetic use, with no pregnancy- or breastfeeding-specific topical concern identified in the material reviewed.
Sources: CIR: Safety Assessment of Hyaluronates as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory
Synthetic acetylated peptide used in topical cosmetic anti-aging and skin-conditioning formulas. Available cosmetic ingredient references do not identify a pregnancy- or breastfeeding-specific concern for normal topical cosmetic use.
Sources: Schagen SK. Topical Peptide Treatments with Effective Anti-Aging Results. Cosmetics. 2017;4(2):16. doi:10.3390/cosmetics4020016; EU CosIng / INCI cosmetic ingredient references.
Crosslinked hyaluronate humectant used to support hydration at the skin surface. Reviewed cosmetic safety sources support normal topical use, with no pregnancy- or breastfeeding-specific topical signal identified.
Sources: CIR: Safety Assessment of Hyaluronates as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory
High-water-binding humectant used to support hydration at the skin surface. Reviewed cosmetic safety sources support normal topical use, with no pregnancy- or breastfeeding-specific topical signal identified in the material reviewed.
Sources: CIR: Safety Assessment of Hyaluronates as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory
paeonia albiflora flower extract is a botanical-derived cosmetic conditioning ingredient. The reviewed identity is not a concentrated essential oil or an oral herbal preparation. Available cosmetic evidence and expected topical exposure did not identify a pregnancy-specific contraindication, although botanical irritation or allergy remains possible.
Sources: CIR ingredient-specific and botanical-family safety assessments; CIR Quick Reference Table https://www.cir-safety.org/supplementaldoc/quick-reference-table-december-2025; European Commission CosIng
Modified hyaluronate humectant and skin-conditioning ingredient. Reviewed cosmetic safety sources support topical hyaluronate ingredients, with no pregnancy- or breastfeeding-specific concern identified for normal cosmetic use.
Sources: CIR: Safety Assessment of Hyaluronates as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory
Glycerin, Sodium Acrylates Crosspolymer-2, Butylene Glycol, Niacinamide, 1,2-Hexanediol, Panthenol, Polyglycerin-3, Glyceryl Polymethacrylate, Caffeine, Lactobacillus Ferment Lysate, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Propanediol, Xanthan Gum, Dipotassium Glycyrrhizate, Ethylhexylglycerin, Adenosine, Sodium Metaphosphate, Caprylyl Glycol, Tryptophan, Hydrolyzed Collagen, Dextrin, Theobroma Cacao Extract, Sodium Hyaluronate, Cyanocobalamin, Paeonia Albiflora Root Extract, Tocopherol, Hydrolyzed Hyaluronic Acid, Acetyl Tetrapeptide-2, Sodium Hyaluronate Crosspolymer, Hyaluronic Acid, Paeonia Albiflora Flower Extract, Sodium Acetylated Hyaluronate
Ingredient ratings refreshed 1 October 2026. Formulas vary by market and can change. Always compare with your packaging.
Manual review 2026-07-13: The recorded formula was manually reviewed. This formula contains Dipotassium Glycyrrhizate, classified as low risk under MamaSkin's pregnancy-screening policy. This is a cautious classification, not a known pregnancy contraindication; see the highlighted ingredient entry for its rationale and sources. The product score is a stored assessment, not a clinical safety guarantee.
No. The recorded formula lists a licorice-derived cosmetic ingredient, not an oral licorice product. Different ingredients and routes of exposure should not be treated as interchangeable. Use the exact ingredient's rating and evidence below, together with any manual-review note; this score does not assess teas, supplements or other licorice formulas.
32 of 32 ingredient entries on this page have a recorded score, evidence summary and source text. That describes documentation coverage, not proof that the finished formula has been clinically tested during pregnancy.
Only if the ingredient list on your packaging matches the recorded formula shown here. Formulas can differ by market and change over time. Compare the full list, not just the product name; report a mismatch if it differs.
No. This page presents a pregnancy-focused product assessment. Do not infer a breastfeeding conclusion from its score or label; breastfeeding requires a separate assessment of the formula and how it is used.